Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Agastiya, Aptose, Aribio, Astrazeneca, Beigene, Coherus, Daiichi Sankyo, Hutchmed, Jiangsu Recbio Technology, Johnson & Johnson, Junshi, Moderna, Newsoara, Novavax, Palisade, Very, Vopec.